Comparative evaluation of the automated Roche TaqMan real-time quantitative human immunodeficiency virus type 1 RNA PCR assay and the Roche AMPLICOR version 1.5 conventional PCR assay

Journal of Clinical Microbiology

Volumn 45, Issue 11, 2007, Pages 3616-3619

  Oliver, Anthony R ^a   Pereira, Spyridon F ^a   Clark, Duncan A ^a  

^a BARTS HEALTH NHS TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; EDETIC ACID; VIRUS RNA;

ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; EVALUATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; NONHUMAN; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REGRESSION ANALYSIS; VIRUS LOAD; VIRUS RESISTANCE;

GENOTYPE; HIV-1; HUMANS; POLYMERASE CHAIN REACTION; PROSPECTIVE STUDIES; RNA, VIRAL; VIRAL LOAD;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 36349034685     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.00221-07     Document Type: Article

References (11)

1. BHIVA Executive Committee. 2005. British HIV Association (BHIVA) guidelines for the treatment of HIV-infected adults with antiretroviral therapy. HIV Med. 6(Suppl. 2):1-61.
2. Erali, M., and D. R. Hillyard. 1998. Evaluation of the ultrasensitive Roche Amplicor HIV-1 Monitor assay for quantitation of human immunodeficiency virus type 1 RNA. J. Clin. Microbiol. 37:792-795.
3. Holland, P. M., R. D. Abramson, R. Watson, and D. H. Gelfand. 1991. Detection of specific polymerase chain reaction product by utilizing the 5′-3′ exonuclease activity of Thermus aquaticus DNA polymerase. Proc. Natl. Acad. Sci. USA 88:7276-7280.
4. Mellors, J. W., C. R. Rinaldo, Jr., P. Gupta, R. M. White, J. A. Todd, and L. A. Kingsley. 1996. Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science 272:1167-1170.
5. Michael, N. L., S. A. Herman, S. Kwok, K. Dreyer, J. Wang, C. Christopherson, J. P. Spadoro, K. K. Young, V. Polonis, F. E. McCutchan, J. Carr, J. R. Mascola, L. L. Jagodzinski, and M. L. Robb. 1999. Development of calibrated viral load standards for group M subtypes of human immunodeficiency virus type 1 and performance of an improved AMPLICOR HIV-1 MONITOR test with isolates of diverse subtypes. J. Clin. Microbiol. 37: 2557-2563.
6. Niesters, H. G. 2004. Molecular and diagnostic clinical virology in real time. Clin. Microbiol. Infect. 10:5-11.
7. Perrin, L., J. M. Pawlotsky, M. Bouvier-Alias, C. Sarrazin, S. Zeuzem, and G. Colucci. 2006. Multicenter performance evaluation of a new TaqMan PCR assay for monitoring human immunodeficiency virus RNA load. J. Clin. Microbiol. 44:4371-4375.
8. Riddler, S. A., and J. W. Mellors. 1997. HIV-1 viral dynamics and viral load measurement: implications for therapy. AIDS Clin. Rev. 1997-1998:47-65.
9. Rodriguez, B., A. K. Sethi, V. K. Cheruvu, W. Mackay, R. J. Bosch, M. Kitahata, S. L. Boswell, W. C. Mathews, D. R. Bangsberg, J. Martin, C. C. Whalen, S. Sieg, S. Yadavalli, S. G. Deeks, and M. M. Lederman. 2006. Predictive value of plasma HIV RNA level on rate of CD4 T-cell decline in untreated HIV infection. JAMA 296:1498-1506.
10. Swanson, P., C. de Mendoza, Y. Joshi, A. Golden, R. L. Hodinka, V. Soriano, S. G. Devare, and J. Hackett, Jr. 2005. Impact of human immunodeficiency virus type 1 (HIV-1) genetic diversity on performance of four commercial viral load assays: LCx HIV RNA Quantitative, AMPLICOR HIV-1 MONITOR v1.5, VERSANT HIV-1 RNA 3.0, and NucliSens HIV-1 QT. J. Clin. Microbiol. 43:3860-3868.
11. Triques, K., J. Coste, J. L. Perret, C. Segarra, E. Mpoudi, J. Reynes, E. Delaporte, A. Butcher, K. Dreyer, S. Herman, J. Spadoro, and M. Peeters. 1999. Efficiencies of four versions of the AMPLICOR HIV-1 MONITOR test for quantification of different subtypes of human immunodeficiency virus type 1. J. Clin. Microbiol. 37:110-116.